ByeAcne/Medication
Accutane vs Spironolactone: Which Path?
For women with persistent moderate-severe acne, the two big-gun options are spironolactone (indefinite hormonal management) or isotretinoin (definitive 5-6 month course). Very different paths.
Reviewed by a licensed physician · Updated May 2026
For women with persistent moderate-to-severe acne unresponsive to standard topicals + oral antibiotics, the two big-gun next steps are spironolactone (a hormonal androgen blocker) and isotretinoin (Accutane — an oral retinoid). Both work; they're very different paths with very different commitments.
Spironolactone is the easier-to-start option. It's a daily pill at 50-100mg, no required blood monitoring after initial baseline labs (sometimes potassium check at 4-6 weeks), fewer side effects, and can be continued indefinitely. The main caveats: it works only while you're taking it (stopping reverses the effect over a few months), and women of reproductive potential must use reliable contraception because spironolactone can affect a developing male fetus. It pairs well with combined oral contraception, topical retinoids, and benzoyl peroxide for a comprehensive regimen.
Isotretinoin is a definitive but more demanding treatment. It's an oral retinoid taken for 5-7 months at a cumulative dose calculated by weight, with the goal of long-term remission. About 70% of patients who complete a full adequate course see lasting clearance for years or permanently. The trade-offs are substantial: monthly blood tests during treatment, iPLEDGE program enrollment for women of childbearing potential (monthly pregnancy tests, two forms of contraception, strict pregnancy prevention because of severe teratogenicity), and side effects including dry skin/lips/eyes, joint aches, occasional mood effects, elevated triglycerides, and rare but serious effects on liver function. Isotretinoin requires a prescribing dermatologist (telehealth pathways exist but are limited) and committed monitoring.
The practical decision: for hormonal-pattern acne in adult women, spironolactone is usually tried first because it's simpler. For severe cystic acne, scarring acne, or acne that has failed multiple lower-level treatments, isotretinoin is considered. Many patients do spironolactone for a year, decide it isn't enough, and move to isotretinoin for definitive treatment.
Why isotretinoin can produce remission
Isotretinoin works through multiple mechanisms simultaneously: drastic reduction in sebaceous gland size and activity, normalization of follicular cell shedding, anti-inflammatory effects, and reduction of C. acnes. The sebaceous gland reduction in particular is partly persistent — even after the drug clears, glands often remain smaller and less active for years.
Spironolactone works only on the androgen receptor and only while it's blocking that receptor. The underlying hormonal environment hasn't changed; the medication is just preventing androgens from acting on glands. When the medication stops, glands resume responding to androgens and acne returns. This is why spironolactone is an indefinite maintenance treatment while isotretinoin can be a finite curative one.
Treatment options a doctor may consider
- Spironolactone 50-100mg daily, indefinite
Lower commitment, requires contraception, works only while taking. 12 weeks to effect.
- Isotretinoin 5-7 month course
Definitive treatment. iPLEDGE enrollment for women. Monthly bloodwork. 70% long-term remission rate.
- Spironolactone first, isotretinoin if needed
Common stepwise approach. Try simpler treatment for 6+ months before escalating.
- Specialist referral for isotretinoin
Most physicians refer to dermatology for prescribing and monthly monitoring.
Your specific regimen depends on your medical history, current medications, and intake photos. Only your physician can determine what's appropriate.
Who this applies to
Women with persistent moderate-severe acne unresponsive to standard topicals + short-course antibiotics. Particularly relevant for choosing between an indefinite-but-easier path (spironolactone) and a finite-but-more-intensive path (isotretinoin).